{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/ovarian-cancer/","result":{"data":{"firstChapter":{"id":"00f52bf3-2854-5c26-896d-9e19a7a50ffa","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field bfc87a10-6b22-4f91-854f-a046054b4354 --><h1>Ovarian cancer: Summary</h1><!-- end field bfc87a10-6b22-4f91-854f-a046054b4354 -->","htmlStringContent":"<!-- begin item d86e7430-aa83-4054-9055-18d503164437 --><!-- begin field 8c8a609f-790d-465e-99d8-ba506bd164b8 --><ul><li>Ovarian cancer is cancer which arises from the ovary.<ul><li>Epithelial cancers account for approximately 90% of primary ovarian cancers and include serous (70–85% of cases), mucinous, endometrioid, clear cell, transitional cell, and squamous tumours.</li><li>Non-epithelial cancers account for approximately 10% of primary ovarian cancers and include germ cell tumours, ovarian carcinosarcoma, sex cord and stromal tumours, small cell and neuroendocrine tumours, squamous cell carcinoma arising within a dermoid cyst or teratoma, and struma ovarii malignum.</li></ul></li><li>Secondary metastatic tumours can occur in the ovary, most notably from cancers of the endometrium, breast, gastrointestinal tract, and cervix (rare).</li><li>Ovarian cancer may spread to intraperitoneal structures and organs (causing intestinal obstruction and cachexia), the liver, para-aortic lymph nodes, and the lungs (causing pleural effusions).</li><li>The lifetime risk of a woman being diagnosed with ovarian cancer is about 1 in 52.</li><li>The risk of ovarian cancer is increased by factors such as increasing age, family history of ovarian or breast cancer, gene mutation, and endometriosis.</li><li>The risk of ovarian cancer is reduced by factors such as an increasing number of pregnancies, breastfeeding, and the use of the combined oral contraceptive pill.</li><li>Ovarian cancer should be suspected and tests carried out in any woman (particularly if over 50 years of age) if any of the following symptoms are persistent or frequent (particularly more than 12 times per month):<ul><li>Abdominal distension (bloating).</li><li>Feeling full (early satiety) and/or loss of appetite.</li><li>Pelvic or abdominal pain.</li><li>Increased urinary urgency and/or frequency.</li></ul></li><li>Ovarian cancer should also be suspected and tests carried out in any woman over 50 years of age if she has had symptoms suggestive of irritable bowel syndrome (IBS) within the last 12 months.</li><li>The possibility of ovarian cancer (and the need to carry out tests) should be considered in a woman who reports any of the following <em>unexplained </em>symptoms:<ul><li>Weight loss.</li><li>Malaise or fatigue.</li><li>Change in bowel habit.</li></ul></li><li>Other symptoms of ovarian cancer that may be present include:<ul><li>Abnormal or postmenopausal bleeding.</li><li>Gastrointestinal symptoms, such as dyspepsia, nausea, and bowel obstruction.</li><li>Shortness of breath (due to pleural effusion).</li></ul></li><li>If ovarian cancer is suspected, examination of the abdomen and pelvis should be carried out.<ul><li>If the woman has ascites or a pelvic or abdominal mass (which is not caused by known uterine fibroids), an urgent referral should be made.</li></ul></li><li>If the examination is normal, measurement of serum CA125 should be undertaken and:<ul><li>If serum CA125 concentration is raised, an urgent ultrasound scan of the pelvis should be arranged and an urgent referral made if this is suggestive of ovarian cancer.</li><li>If serum CA125 is normal, or raised with a normal ultrasound, other causes for the symptoms should be considered and investigated appropriately. If no other cause is apparent, the woman should be advised to return if her symptoms become more frequent and/or persistent.</li></ul></li></ul><!-- end field 8c8a609f-790d-465e-99d8-ba506bd164b8 --><!-- end item d86e7430-aa83-4054-9055-18d503164437 -->","topic":{"id":"e76d1533-c4e4-5615-b47d-b9a78e802a8c","topicId":"2b5f9995-52a6-4997-b11b-4dd86f5b4cac","topicName":"Ovarian cancer","slug":"ovarian-cancer","aliases":[],"chapters":[{"id":"00f52bf3-2854-5c26-896d-9e19a7a50ffa","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"1978d14c-1832-5012-aad2-ae688f64a4f0","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"39ed13eb-bf02-5897-9546-f63bb13e1312","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"b6205ec5-8fed-5fa0-9459-17c9ed9797a4","slug":"changes","fullItemName":"Changes"},{"id":"dff67d8b-2740-5711-b49a-d03a83243ab3","slug":"update","fullItemName":"Update"}]},{"id":"4d027c28-c2b3-5578-8eab-c2029d5b3347","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"f40d2697-554a-5249-abb4-6247e9db5eca","slug":"goals","fullItemName":"Goals"},{"id":"6b3fba32-56cd-5102-879a-64cb859b80ef","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8e5550d6-e4d8-54a5-8046-0542cdf4be38","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c7811d8a-c44d-5470-8e72-e0a8ff4d2d61","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"816a9080-6571-5a58-bfe1-04411127e3d2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4afe1f86-c28e-51bf-8c7f-39373606165d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"39f05ca6-5cf0-5e67-af39-03983de815d1","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"03b4909c-fc38-5af3-848f-1df54131e0c5","slug":"definition","fullItemName":"Definition"},{"id":"83553e71-1f1a-543b-be50-09b4c7b8c224","slug":"incidence","fullItemName":"Incidence"},{"id":"c8597bdc-f028-5141-85c3-c6b429bf7d78","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"e5f859f0-168b-5395-a133-af2778a0ef84","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4d5f7685-3efd-5198-90e1-d8cb8f470a28","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"26a540a4-c12b-5ae8-b3de-eb2d3472a824","slug":"when-to-suspect-ovarian-cancer","fullItemName":"When to suspect ovarian cancer"},{"id":"d7d39f7a-9f30-588c-9589-b8c8b5a76729","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d02788d8-8b2d-5672-8eca-dfcc643a2055","slug":"management","fullItemName":"Management","subChapters":[{"id":"e47609d5-133b-5929-ad56-44ab30116871","slug":"managing-a-woman-with-suspected-ovarian-cancer","fullItemName":"Scenario: Managing a woman with suspected ovarian cancer"}]},{"id":"99dcdee4-9931-5ef8-a3d8-d86417646b02","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"9b4bd4c6-cb71-5783-8529-7346c25fc30f","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"11ba9663-4a8b-516e-a825-1f8d766c7041","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"ec67bf69-9ccc-5c53-81da-f2c0713d4527","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bcf5ab6b-23af-5b9a-bbcd-22d0002e20cf","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ac95df2b-f68f-5f64-bb51-88ff094f74b8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"23bfe348-903c-5728-b9b9-71e7975e7e53","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"faaa4aff-4567-544b-af9e-b7dc24fae5df","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"e76d1533-c4e4-5615-b47d-b9a78e802a8c","topicId":"2b5f9995-52a6-4997-b11b-4dd86f5b4cac","topicName":"Ovarian cancer","slug":"ovarian-cancer","aliases":[],"topicSummary":"The lifetime risk of a woman being diagnosed with ovarian cancer is 1 in 52.The risk of ovarian cancer is increased by:Increasing age.","lastRevised":"Last revised in July 2018","nextPlannedReviewBy":"2023-07-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2023-06","nextPlannedReviewByDisplay":"June 2023","specialities":[{"id":"46239e57-7990-560a-810f-b31000558649","name":"Cancer","slug":"cancer"},{"id":"0c813417-9691-5826-9371-c4bec6c53f06","name":"Women's health","slug":"womens-health"}],"chapters":[{"id":"00f52bf3-2854-5c26-896d-9e19a7a50ffa","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"1978d14c-1832-5012-aad2-ae688f64a4f0","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"39ed13eb-bf02-5897-9546-f63bb13e1312","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"b6205ec5-8fed-5fa0-9459-17c9ed9797a4","slug":"changes","fullItemName":"Changes"},{"id":"dff67d8b-2740-5711-b49a-d03a83243ab3","slug":"update","fullItemName":"Update"}]},{"id":"4d027c28-c2b3-5578-8eab-c2029d5b3347","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"f40d2697-554a-5249-abb4-6247e9db5eca","slug":"goals","fullItemName":"Goals"},{"id":"6b3fba32-56cd-5102-879a-64cb859b80ef","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8e5550d6-e4d8-54a5-8046-0542cdf4be38","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c7811d8a-c44d-5470-8e72-e0a8ff4d2d61","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"816a9080-6571-5a58-bfe1-04411127e3d2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4afe1f86-c28e-51bf-8c7f-39373606165d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"39f05ca6-5cf0-5e67-af39-03983de815d1","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"03b4909c-fc38-5af3-848f-1df54131e0c5","slug":"definition","fullItemName":"Definition"},{"id":"83553e71-1f1a-543b-be50-09b4c7b8c224","slug":"incidence","fullItemName":"Incidence"},{"id":"c8597bdc-f028-5141-85c3-c6b429bf7d78","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"e5f859f0-168b-5395-a133-af2778a0ef84","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4d5f7685-3efd-5198-90e1-d8cb8f470a28","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"26a540a4-c12b-5ae8-b3de-eb2d3472a824","slug":"when-to-suspect-ovarian-cancer","fullItemName":"When to suspect ovarian cancer"},{"id":"d7d39f7a-9f30-588c-9589-b8c8b5a76729","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d02788d8-8b2d-5672-8eca-dfcc643a2055","slug":"management","fullItemName":"Management","subChapters":[{"id":"e47609d5-133b-5929-ad56-44ab30116871","slug":"managing-a-woman-with-suspected-ovarian-cancer","fullItemName":"Scenario: Managing a woman with suspected ovarian cancer"}]},{"id":"99dcdee4-9931-5ef8-a3d8-d86417646b02","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"9b4bd4c6-cb71-5783-8529-7346c25fc30f","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"11ba9663-4a8b-516e-a825-1f8d766c7041","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"ec67bf69-9ccc-5c53-81da-f2c0713d4527","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bcf5ab6b-23af-5b9a-bbcd-22d0002e20cf","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ac95df2b-f68f-5f64-bb51-88ff094f74b8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"23bfe348-903c-5728-b9b9-71e7975e7e53","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"faaa4aff-4567-544b-af9e-b7dc24fae5df","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"e76d1533-c4e4-5615-b47d-b9a78e802a8c"}},"staticQueryHashes":["3666801979"]}